1. Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway.
- Author
-
Ma L, Zhu Y, Fang S, Long H, Liu X, and Liu Z
- Subjects
- A549 Cells, Amino Acid Chloromethyl Ketones pharmacology, Amphibian Venoms chemistry, Antineoplastic Agents isolation & purification, Apoptosis genetics, Bufanolides isolation & purification, Caspase 3 genetics, Caspase 3 metabolism, Caspase 9 genetics, Caspase 9 metabolism, Cell Line, Tumor, Cell Survival drug effects, Humans, Medicine, Chinese Traditional, Myeloid Cell Leukemia Sequence 1 Protein antagonists & inhibitors, Myeloid Cell Leukemia Sequence 1 Protein genetics, Myeloid Cell Leukemia Sequence 1 Protein metabolism, Poly(ADP-ribose) Polymerases genetics, Poly(ADP-ribose) Polymerases metabolism, Proto-Oncogene Proteins c-bcl-2 antagonists & inhibitors, Proto-Oncogene Proteins c-bcl-2 metabolism, RNA, Small Interfering genetics, RNA, Small Interfering metabolism, Respiratory Mucosa drug effects, Respiratory Mucosa metabolism, Respiratory Mucosa pathology, Signal Transduction, Tumor Suppressor Protein p53 agonists, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Antineoplastic Agents pharmacology, Apoptosis drug effects, Bufanolides chemistry, Bufanolides pharmacology, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-bcl-2 genetics
- Abstract
Arenobufagin, an active component isolated from the traditional Chinese medicine Chan Su, exhibits anticancer influences in several human malignancies. However, the effects and action mechanisms of arenobufagin on non-small-cell lung cancer (NSCLC) are still unknown. In this study, we reported that arenobufagin acted through activation of Noxa-related pathways and promoted apoptotic cell death in human NSCLC cells. Our results revealed that arenobufagin-induced apoptosis was caspase-dependent, as evidenced by the fact that caspase-9, caspase-3 and poly (ADP-ribose) polymerase (PARP) were cleaved, and pretreatment with a pan-caspase inhibitor Z-VAD-FMK inhibited the pro-apoptosis effect of arenobufagin. Mechanistically, we further found that arenobufagin rapidly upregulated the expression of the pro-apoptosis protein Noxa, and abrogated the anti-apoptosis protein Mcl-1, a major binding partner of Noxa in the cell. More importantly, the knockdown of Noxa greatly blocked arenobufagin-induced cell death, highlighting the contribution of this protein in the anti-NSCLC effects of arenobufagin. Interestingly, arenobufagin also increased the expression of p53, a direct transcriptional activator for the upregulation of the Noxa protein. Taken together, our results suggest that arenobufagin is a potential anti-NSCLC agent that triggers apoptotic cell death in NSCLC cells through interfering with the Noxa-related pathway., Competing Interests: The authors declare no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF